Chester, PA (PRWEB) May 19, 2008
Thornton-Cleveleys, UK (PRWEB) May 19, 2008 -- Invibio Biomaterial Solutions, a worldwide leading provider of high-performance implantable biomaterials to the surgical and medical device markets, announced today that it has entered into a collaboration programme with Smith & Nephew for the development of a next generation family of structural bioresorbable polymers.
The programme will seek to develop advanced structural bioresorbable materials with the performance specifications needed for more rigid, load bearing applications typically not attainable by today's resorbable biomaterial technologies.
The partnership will leverage the complementary strengths of these two market-leading companies. Invibio is a recognized leader in the development and commercialization of novel polymeric biomaterials and associated solutions to a broad spectrum of medical implant markets. The programme demonstrates Invibio's continued focus to provide unique families of biomaterials which compliment their existing polyketone offerings. Smith & Nephew, a leading global medical technologies company, has a long history of innovation and the development of advanced medical devices, including leading edge bioresorbable materials.
The development collaboration between Invibio and Smith & Nephew is an initial three year project, and is co-funded by the Technology Strategy Board's Collaborative Research and Development programme, following an open competition. The Technology Strategy Board is an executive body established by the Government of the United Kingdom to drive innovation. It promotes and invests in research, development and the exploitation of science, technology and new ideas for the benefit of business -- increasing sustainable economic growth in the UK and improving quality of life. For more information visit http://www.innovateuk.org.
Invibio is a global leader providing high performance biomaterials, advanced technical research and consultative solutions to medical device manufacturers across a wide range of markets. The company provides medical device manufacturers with implantable-grade PEEK-OPTIMA® and ENDOLIGN® polymers and medical-grade PEEK-CLASSIX® polymer for the development of long- and short-term implantable medical devices.
For more information, please contact Invibio at: 866 468 4246 or +484 342 6004(U.S.), +44 (0) 1253 898000 (U.K.), +852 2366 4448 (Asia Pacific) or online at http://www.invibio.com.
# # #